Please use this identifier to cite or link to this item:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/5110Full metadata record
| ???org.dspace.app.webui.jsptag.ItemTag.dcfield??? | Value | Language |
|---|---|---|
| dc.contributor.advisor | 楊銘欽(Ming-Chin Yang) | |
| dc.contributor.author | Ling-Chih Su | en |
| dc.contributor.author | 蘇玲枝 | zh_TW |
| dc.date.accessioned | 2021-05-15T17:52:02Z | - |
| dc.date.available | 2016-03-12 | |
| dc.date.available | 2021-05-15T17:52:02Z | - |
| dc.date.copyright | 2015-03-12 | |
| dc.date.issued | 2014 | |
| dc.date.submitted | 2014-12-15 | |
| dc.identifier.citation | 1. 曾旭民, 盧瑞芬, 蔡益堅. 國人生活品質評量 (Ⅱ): SF-36 台灣版的常模與效度檢測. 臺灣公共衛生雜誌. 2003;22(6):512-518.
2. Food and Drug Administration U. Guidance for Industry on Patient-Reported Outcome Measures:Use in Medical Product Development to Support Labeling Claims. 2009. 3. Marshall S, Haywood K, Fitzpatrick R. Impact of patient‐reported outcome measures on routine practice: a structured review. Journal of evaluation in clinical practice. 2006;12(5):559-568. 4. 陳玉黛, 蔡秀鸞, 林佩芬. 肌無力症病患疾病感受, 情緒與生活品質之相關性探討. 護理雜誌. 2003;50(6):43-50. 5. Paul RH, Nash JM, Cohen RA, Gilchrist JM, Goldstein JM. Quality of life and well‐being of patients with myasthenia gravis. Muscle & nerve. 2001;24(4):512-516. 6. Padua L, Evoli A, Aprile I, et al. Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements. Neurological Sciences. 2001;22(5):363-369. 7. Rostedt A, Padua L, Stalberg EV. Correlation between regional myasthenic weakness and mental aspects of quality of life. European journal of neurology. 2006;13(2):191-193. 8. Raggi A, Leonardi M, Antozzi C, et al. Concordance between severity of disease, disability and health-related quality of life in Myasthenia gravis. Neurological sciences. 2010;31(1):41-45. 9. Leonardi M, Raggi A, Antozzi C, et al. The relationship between health, disability and quality of life in Myasthenia Gravis: results from an Italian study. Journal of neurology. 2010;257(1):98-102. 10. Raggi A, Leonardi M, Mantegazza R, Casale S, Fioravanti G. Social support and self-efficacy in patients with Myasthenia Gravis: a common pathway towards positive health outcomes. Neurological sciences. 2010;31(2):231-235. 11. Basta IZ, Pekmezović TD, Perić SZ, et al. Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia). Neurological Sciences. 2012;33(6):1375-1381. 12. Jaretzki A, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis Recommendations for clinical research standards. Neurology. 2000;55(1):16-23. 13. Padua L, Evoli A, Aprile I, et al. Myasthenia gravis outcome measure: development and validation of a disease-specific self-administered questionnaire. Neurological Sciences. 2002;23(2):59-68. 14. Padua L, Galassi G, Ariatti A, et al. Myasthenia gravis self-administered questionnaire: development of regional domains. Neurological Sciences. 2005;25(6):331-336. 15. Mullins LL, Carpentier MY, Paul RH, Sanders DB. Disease‐specific measure of quality of life for myasthenia gravis. Muscle & nerve. 2008;38(2):947-956. 16. Burns TM, Conaway MR, Cutter GR, Sanders DB. Less is more, or almost as much: A 15‐item quality‐of‐life instrument for myasthenia gravis. Muscle & nerve. 2008;38(2):957-963. 17. Mourao AM, Araujo CM, Barbosa LSM, et al. Brazilian cross-cultural translation and adaptation of the' Questionnaire of Life Quality Specific for Myasthenia Gravis-15 items'. Arquivos de neuro-psiquiatria. 2013;71(12):955-958. 18. Liu F-b, Chen X-l, Guo L, Liu X-b. Evaluation of a scale of patient-reported outcomes for the assessment of myasthenia gravis patients in China. Chinese journal of integrative medicine. 2012;18:737-745. 19. Masuda M, Utsugisawa K, Suzuki S, et al. The MG‐QOL15 Japanese version: Validation and associations with clinical factors. Muscle & nerve. 2012;46(2):166-173. 20. Martinez‐Lapiscina EH, Erro ME, Ayuso T, Jerico I. Myasthenia gravis: sleep quality, quality of life, and disease severity. Muscle & nerve. 2012;46(2):174-180. 21. Maniaol A, Brunborg C, Tallaksen C. Development and validation of a self-administered questionnaire for myasthenia gravis patients. Neuroepidemiology. 2010;34(4):253-261. 22. Utsugisawa K, Suzuki S, Nagane Y, et al. Health‐Related Quality of Life and Treatment Targets in Myasthenia Gravis. Muscle & nerve. 2014. 23. Kulaksizoglu IB. Mood and Anxiety Disorders in Patients with Myasthenia Gravis. CNS drugs. 2007;21(6):473-481. 24. 邱浩彰, 葉建宏. 神經科: 肌無力症在台灣的臨床觀察與治療原則. 臺灣醫學. 1997;1(5):658-662. 25. Burns TM. History of outcome measures for myasthenia gravis. Muscle & nerve. 2010;42(1):5-13. 26. MANTEGAZZA R, BAGGI F, ANTOZZI C, et al. Myasthenia gravis (MG): epidemiological data and prognostic factors. Annals of the New York Academy of Sciences. 2003;998(1):413-423. 27. PHILLIPS LH. The epidemiology of myasthenia gravis. Annals of the New York Academy of Sciences. 2003;998(1):407-412. 28. Black N. Patient reported outcome measures could help transform healthcare. BMJ. 2013;346:f167. 29. Cappelleri JC, Zou KH, Bushmakin AG, Alvir JMJ, Alemayehu D, Symonds T. Patient-Reported Outcomes. Measurement,Implementation and Interpretation. 2014. 30. 薛亞聖. 建構台灣地區永續性生活品質指標評量系統-醫療品質指標之建立 (I). 2002. 31. 盧瑞芬, 曾旭民, 蔡益堅. 國人生活品質評量 (Ⅰ): SF-36 台灣版的發展及心理計量特質分析. 臺灣公共衛生雜誌. 2003;22(6):501-511. 32. Rostedt A, Padua L, Stalberg E. Validation of the Swedish version of the disease-specific Myasthenia Gravis Questionnaire. Neurological Sciences. 2006;27(2):91-96. 33. Basta I, Pekmezović T, Padua L, et al. Validation of Serbian version of the disease‐specific myasthenia gravis questionnaire. Acta Neurologica Scandinavica. 2010;122(2):110-114. 34. Rostedt A, Padua L, Stalberg EV. Correlation between a patient-derived functional questionnaire and abnormal neuromuscular transmission in Myasthenia Gravis patients. Clinical neurophysiology. 2005;116(9):2058-2064. 35. Paul RH, Cohen RA, Goldstein JM, Gilchrist JM. Fatigue and its impact on patients with myasthenia gravis. Muscle & nerve. 2000;23(9):1402-1406. 36. Emery EJ, Szymanski HV. Psychological symptoms preceding diagnosed myasthenia gravis. Psychosomatics. 1981;22(11):993-995. 37. Rohr W. [Myasthenia gravis in the frontier of psychiatric diagnosis]. Psychiatrische Praxis. 1992;19(5):157-163. 38. Ybarra MI, Kummer A, Frota ERC, Oliveira JTd, Gomez RS, Teixeira AL. Psychiatric disorders in myasthenia gravis. Arquivos de neuro-psiquiatria. 2011;69(2A):176-179. 39. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta psychiatrica scandinavica. 1983;67(6):361-370. 40. 劉棻, 劉雪娥. 截肢病患支持團體的發展與設計. 高雄護理雜誌. 2011;28(3):31-41. 41. Halm M. Strategies for developing a family support group. Focus on critical care/American Association of Critical-Care Nurses. 1991;18(6):444-455, 458-449. 42. Cain EN, Kohorn EI, Quinlan DM, Latimer K, Schwartz PE. Psychosocial benefits of a cancer support group. Cancer. 1986;57(1):183-189. 43. Burns TM, Grouse C, Conaway MR, Sanders DB. Construct and concurrent validation of the MG‐QOL15 in the practice setting. Muscle & nerve. 2010;41(2):219-226. 44. Burns TM, Grouse C, Wolfe GI, Conaway MR, Sanders DB. The MG‐QOL15 for following the health‐related quality of life of patients with myasthenia gravis. Muscle & nerve. 2011;43(1):14-18. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/5110 | - |
| dc.description.abstract | 肌無力症是神經肌肉的自體免疫疾病,患者會有上眼臉下垂、複視、口齒不清、吞嚥困難、全身無力等症狀,嚴重時甚至呼吸困難導致生命危險。隨著醫療科技發展,肌無力症不論在診斷及治療都有進步,平均餘命延長及人口老化等因素,其盛行率有增加之趨勢。參考全民健康保險重大傷病領證人數,推估台灣肌無力症盛行率每百萬人口約187人。由於疾病的特性會使患者身體上出現的障礙,影響生活上的自理能力,也會影響其社交、工作、求學的機會及心理層面,進而影響其生活品質。本研究利用病人自行報告之結果,透過患者自填問卷的方式獲得其健康相關的生活品質報告,以作為協助醫師提供更好更多的以病人為中心的照護服務。
本研究採橫斷式調查研究,以單一醫院的門診肌無力症患者為研究樣本,個人為分析單位。資料來自兩方面,健康生活品質及社會及人口學方面,以結構式問卷進行調查;臨床資料方面,以樣本醫院提供之肌無力患者資料庫登錄資料為準。本研究自103年7月1日至8月31日進行調查,共回收問卷132份,其中116份為有效問卷(有效樣本率為88%),收案病患平均年齡46.4歲,其中女性有78位。利用統計軟體SPSS 17.0,以雙變項分析及線性迴歸分析,檢定各變項與生活品質之關係。研究結果顯示,不同焦慮程度是影響生活品質主要因子,焦慮分數越高,生活品質越差;在分層分析中顯示,最年長的一組其憂鬱程度會影響生活品質,但有擔任肌無力俱樂部幹部對生活品質有正向效果。 情緒障礙是肌無力症患者最常見的併發症,在治療肌無力症的同時,心理的健康也是醫療團隊應積極維護的。肌無力俱樂部具有提升生活品質的功能,在年長的樣本中得到驗證,建議可以多鼓勵所有病友參加幹部的培訓課程,讓病友轉換生病者的角色,成為主動關懷的人,對於其生活品質會有所助益。臨床上,建議對肌無力患者進行全面的生活品質量表及焦慮憂鬱量表調查,以瞭解患者生活品質及心理狀況,對於焦慮憂鬱患者能及早介入治療,以維護其生活品質。 | zh_TW |
| dc.description.abstract | Myasthenia Gravis(MG)is a neuromuscular autoimmune disease. Patients will have symptoms like ptosis, diplopia, dysarthria, dysphagia, generalized muscle weakness, and, in the most severe situation, respiratory insufficiently, even leading to life-threatening. As medical technology developing, there has been great progress in the diagnosis and treatment of myasthenia gravis. Due to longer life expectancy and aging population, there is a clear trend towards an increase in the prevalence of the disease. According to the number of valid catastrophic illness cards issued by Taiwan’s National Health Insurance, the prevalence of myasthenia gravis in Taiwan is estimated to be 187 cases per million people. Due to the nature of the disease, patients are affected in self-care ability, social, work, pursuing education opportunities and psychological aspect, thereby affecting their quality of life. In this study, using patient-reported outcome, obtained the quality-of-life through asking patients to fill out a self-administered questionnaire directly. The results will be provided to the clinicians to deliver better patient-centered service.
This study was a cross-sectional research. Patients were recruited from the outpatient neurology clinic of a single hospital, individuals as ananlysis unit. Data were obtained from two parts. Health-related quality-of-life and socio-demographic features were collected from the structured questionnaires, and clinical data were acquired from the database registered in the sample hospital. The study was conducted between 1st July 2010 and 31st August 2014. There were 132 questionnaires collected, of which there were 116 valid questionnaires (effective sample rate of 88%). The recruited patients’ average age was 46.4 years, 78 were female.Using the statistical software SPSS 17.0, with bivariate analysis and linear regression analysis to test the relationship between various variables and quality of life. The results reveal that the different degrees of anxiety were the main factor affecting the quality of life, the higher anxiety’s score was, the worse quality of life became. Stratified analyses showed that the different degrees of depression affected the quality of life in the oldest group. But the samples served as volunteer’s cadres in MG club had positive effect on quality of life. Mood disorder is the most common co-morbidity in MG patients. In the treatment of myasthenia gravis, mental health should be actively maintained. MG club had a function to enhance the quality of life of patients; it had been verified in the oldest group of patients. It is recommended that more patients be encouraged to attend the training courses of volunteer cadres. It will help the patients convert the sick role to become an active person of delivering care for other patients. Therefore the quality-of-life of patients will be improved. Clinically, in order to understand the quality of life and psychological status of patients with MG, it is recommended to conduct a comprehensive investigation of quality-of-life scale and Hospital Anxiety Depression Scale. Early intervention will be provided to patients with anxiety or depression so as to maintain their quality-of-life. | en |
| dc.description.provenance | Made available in DSpace on 2021-05-15T17:52:02Z (GMT). No. of bitstreams: 1 ntu-103-R01847012-1.pdf: 2757847 bytes, checksum: 9024a672a6970344918c9a8596b2f2f3 (MD5) Previous issue date: 2014 | en |
| dc.description.tableofcontents | 誌謝 i
中文摘要 ii ABSTRACT iii 目 錄 v 圖目錄 viii 表目錄 ix 附表目錄 xi 第一章 前言 1 第一節 實習單位特色與簡介 1 第二節 研究背景與動機 2 第二章 文獻探討 4 第一節 肌無力症(Myasthenia Gravis, MG) 4 第二節 病人自行報告之結果(Patient-Reported Outcome, PRO) 5 第三節 肌無力症生活品質量表 6 一、 SF-36(Medical Outcome Study Short Form, MOS SF-36) 6 二、 MGQ(Myasthenia Gravis Questionnaire,25-item) 7 三、 MG-QOL-60(Myasthenia Gravis Quality of Life,60-item) 8 四、 MG-QOL-15(Myasthenia Gravis Quality of Life,15-item) 8 五、 挪威版肌無力症的環境及潛在誘發因子問卷 9 第四節 醫院焦慮與憂鬱量表 10 第五節 病友支持團體 10 第三章 研究方法 12 第一節 研究設計 12 一、 研究對象 12 二、 研究架構 13 第二節 研究假說 14 第三節 研究材料與工具 15 一、 研究材料 15 二、 研究工具 15 三、 操作型定義 16 第四節 研究步驟 18 一、 前驅試驗 19 二、 正式研究 20 第五節 資料處理與分析方法 21 一、 資料處理 21 二、 統計分析方法 24 第六節 研究倫理 24 第四章 研究結果與分析 25 第一節 描述性統計分析 25 一、 社會及人口學特性 25 二、 健康相關生活品質 25 三、 焦慮憂鬱狀態 26 第二節 推論性統計分析 30 一、 雙變項統計分析 30 二、 迴歸統計分析 40 第五章 討論與建議 54 第一節 研究假說驗證與討論 54 一、 研究假說驗證 54 二、 討論 56 第二節 研究限制 59 第三節 結論與建議 59 參考文獻 61 附錄 64 | |
| dc.language.iso | zh-TW | |
| dc.subject | 病友支持團體 | zh_TW |
| dc.subject | 肌無力症 | zh_TW |
| dc.subject | 病人自行報告之結果 | zh_TW |
| dc.subject | 健康相關生活品質量表 | zh_TW |
| dc.subject | Health-Related Quality-of-Life (HR-QOL) | en |
| dc.subject | Patients Support Group | en |
| dc.subject | Patient-Reported Outcome (PRO) | en |
| dc.subject | Myasthenia Gravis (MG) | en |
| dc.title | 肌無力症患者生活品質與焦慮憂鬱之相關因素 | zh_TW |
| dc.title | Factors Associated with Quality of Life, Anxiety, and Depression in Patients with Myasthenia Gravis | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 103-1 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 邱浩彰(Hou-Chang Chiu),鍾國彪(Kuo-Piao Chung) | |
| dc.subject.keyword | 肌無力症,病人自行報告之結果,健康相關生活品質量表,病友支持團體, | zh_TW |
| dc.subject.keyword | Myasthenia Gravis (MG),Patient-Reported Outcome (PRO),Health-Related Quality-of-Life (HR-QOL),Patients Support Group, | en |
| dc.relation.page | 74 | |
| dc.rights.note | 同意授權(全球公開) | |
| dc.date.accepted | 2014-12-15 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 公共衛生碩士學位學程 | zh_TW |
| Appears in Collections: | 公共衛生碩士學位學程 | |
Files in This Item:
| File | Size | Format | |
|---|---|---|---|
| ntu-103-1.pdf | 2.69 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
